Retrospective analysis of the prevalence, characteristics, therapy and outcomes of diverticular disease according to the data of a multidisciplinary hospital

Aim of investigation: to study the prevalence, characteristics, therapy and outcomes of diverticular disease (DD) according to the data of a multidisciplinary hospital.

Material and methods: the retrospective survey included 50 patients treated in the Voronezh Region Clinical Hospital № 1 in the period from 2016 to 2018 according to the following characteristics: age and gender, number of previous hospitalizations associated with DD and complications of diverticulosis,  the results of clinical diagnostic and instrumental examination data, conservative treatment and surgical interventions.

Results: Within the discovered data there were 38 (79.1%) emergency and 12 (20.9%) planned admissions. Gender diff erences were established with the predominance of female patients: 28 women (56%) and 22 men (44%) respectively. According to age diff erences 4 patients were under 30 years (8%), 7 — from 31 to 40 years (14%), 13 — from 41 to 50 years (26%), 17 — from 51 to 60 years (34%), 9 people were older than 61 years (18%). The average age was 39.2 ± 2.1 years.
The majority of patients were of working age. Acute diverticulitis was the predominant form of DB — 28 (56%) cases. Bleeding was detected in 2 (4%) cases, peridiverticular infi ltrate — in 4 (8%) cases, peridiverticular abscess — in 3 (6%) cases, and recurrent chronic diverticulitis — in 13
(26%) cases. Repeated development of DD complications over a three-year follow — up period was found in 40 (80%) patients. Of the 28 (56%) patients with acute diverticulitis who did not receive anti-relapse treatment, 21 (42%) were subsequently operated on for DD complications.

Conclusion: 1. The results of the performed analysis showed that every second patient with DD was of working age (up to 68 years). In the period from 2016 to 2018, there was a tendency of increase in the incidence of DD in patients of all age groups. 

2. Acute diverticulitis was the predominant form of DB (56%). Peridiverticular infi ltrate and peridiverticular abscess were detected in 8% and 6% of cases respectively.

3. Within three years, repeated development of DD complications was observed in 40 (80%) patients of the studied sample. Of the 28 patients (56%) with acute diverticulitis treated conservatively and not receiving anti-relapse therapy, 21 people (42%) were subsequently operated on for complications of DD.

1. Vorobyev G. I. Osnovi koloproktologii. – Мoscow, 2006. 432 p. (In Russian)

2. Tursi A. Diverticulosis today: unfashionable and still underresearched. Therap Adv Gastroenterol. 2016; 9:213–228.

3. Ardatskaya M. D. Diverticular disease of the colon: resolved and unresolved issues. Medical Council. 2017;15: 68–75. (In Russian).

4. Golovanova E. V. Cyclic rifaximin and soluble dietary fiber therapy for symptomatic diverticular disease: effective prevention of complications. Medical Council. 2019; 3: 98–107. (In Russian).

5. Ivashkin V. T., Shelygin Yu.A., Achkasov S. I., et al. Diagnostics and treatment of diverticular disease of the colon: guidelines of the Russian gastroenterological Association and Russian Association of Coloproctology. RJGHC. 2016; 1: 65–80. (In Russian).

6. Francis N.K., Sylla P., Abou Khalil M, et al. EAES and SAGES2018 consensus conference on acute diverticulitis management: evidence based recommendations for clinical practice. Surgical Endoscopy. 2019; 33: 2726–2741.

7. Jamal Talabani A, Lydersen S, Endreseth BH, Edna TH Major increase in admission- and incidence rates of acute colonic diverticulitis. Int J Colorectal Dis. 2014; 29 (8):937–45.

8. Etzioni D.A., Mack T. M., Beart R. W., et al. Diverticulitis in the United States: 1998–2005. Changing patterns of disease and treatment. Ann Surg. 2009; 249(2): 210–7.

9. Tursi A., Scarpignato C., Brandimarte G., Di Mario F., Lanas A. Rifaximin for the management of colonic diverticular disease: Far beyond a simple antibiotic. J Gastrointestin Liver Dis. 2018; 27(4): 351–355.

10. Quigley E. M. M. Gut Microbiota, Infl ammation and Symptomatic Diverticular Disease. New Insights into an Old and Neglected Disorder. Journal of gastrointestinal and liver diseases. 2010; 19: 127–129.

11. Timerbulatov M. V., Kulyapin A. V., Lopatin D. V. A retrospective analysis of the treatment of patients with inflammatory complications of diverticular disease of the colon. Bashkortostan Medical Journal. 2017, vol.12, no. 4 (70), pp. 5–9. (In Russian).

12. Yamada E., Inamori M., Uchida E. et al. Association between the location of diverticular disease and the irritable bowel syndrome: a multicenter study in Japan. Am J Gastroenterol. 2014; 109: 1900–1905.

13. Kruchinina М. А. Diverticularnaya bolezn’ Tolstoy kishki: lecheniye I profi laktika oslozhneniy v usloviyakh polikliniki. Diss. kand. med. nauk [Diverticular colon disease: diagnosis, treatment, and prevention of exacerbations in a polyclinic. Candidate diss.]. Мoscow, 2015. 166 p. (In Russian).

14. Bolokhov K. V. Ostriye vospalitel’niye oslozhneniya diverticularnoy bolezni obodochnoy kishki (klinika, diagnostika, lecheniye). Avtoreferat diss. kand. med. nauk [Acute inflammatory complications of diverticular colon disease (clinic, diagnosis, treatment). Candidate diss.]. Мoscow, 2006. 30 p. (In Russian).

15. Timerbulatov M. V. Diverticularnaya bolezn’ tolstoy kishki. – Мoscow, Medicinskaya kniga, 2016. 215 p. (In Russian).